Orion Pharma Limited (DSE:ORIONPHARM)
Bangladesh · Delayed Price · Currency is BDT 26.40
+0.20 (0.76%)
At close: Sep 3, 2026
Orion Pharma Market Cap
Orion Pharma has a market cap or net worth of 6.18 billion as of September 4, 2026. Its market cap has decreased by -37.44% in one year.
Market Cap
6.18B
Enterprise Value
34.49B
Revenue
3.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
26.40
ChartMarket Cap Chart
Since March 20, 2013, Orion Pharma's market cap has decreased from 14.66B to 6.18B, a decrease of -57.87%. That is a compound annual growth rate of -6.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 6.18B | -3.65% |
| Dec 30, 2025 | 6.41B | -27.70% |
| Dec 30, 2024 | 8.87B | -52.39% |
| Dec 28, 2023 | 18.63B | -3.75% |
| Dec 29, 2022 | 19.35B | -9.22% |
| Dec 30, 2021 | 21.32B | 66.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beacon Pharmaceuticals | 24.62B |
| The ACME Laboratories | 16.74B |
| Asiatic Laboratories | 13.34B |
| The IBN SINA Pharmaceutical Industry | 9.84B |
| Navana Pharmaceuticals | 7.26B |
| Techno Drugs | 5.87B |
| Indo-Bangla Pharmaceuticals | 2.03B |
| Silco Pharmaceuticals | 1.85B |